Marinus Pharmaceuticals to Present at the Cowen Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq drops as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Marinus Pharmaceuticals (MRNS) PT Raised to $24.50 at Ladenburg Thalmann
March 6, 2019 1:35 PM ESTLadenburg Thalmann analyst Michael Higgins raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $24.50 (from $22.00) while maintaining a Buy rating.
... More